OBJECTIVE: The role of osteoprotegerin (OPG) and its receptor activator of nuclear factor kappaB legend (RANKL) in the regulation of bone in humans remain unclear. We examined the sex-specific associations of serum OPG, RANKL, and their ratio with bone mineral density (BMD) in older adults. DESIGN: Participants were 681 community-dwelling adults, ages 45-90 years, who had serum OPG and RANKL measured and bone density scans in 1988-1991, with follow-up scans 5 and/or 10 years later. METHODS: Analyses were sex-specific; women using and not using estrogen were evaluated separately. Cross-sectional analyses used multivariable regression models; longitudinal analyses used repeated measures mixed effects models. RESULTS: In cross-sectional analyses, age- and weight-adjusted serum OPG levels were significantly positively associated with BMD at the lumbar spine in men, and at the femoral neck, total hip, and lumbar spine in women using estrogen, but not in non-users of estrogen. RANKL concentrations were significantly and inversely associated with BMD in men only, and at the total hip. Neither OPG nor RANKL was significantly associated with bone loss. Results for the RANKL/OPG ratio were the same as those for RANKL alone. CONCLUSIONS: These results suggest a modulatory effect of both endogenous and exogenous sex hormones on the biologic interaction of OPG, RANKL, and bone.
OBJECTIVE: The role of osteoprotegerin (OPG) and its receptor activator of nuclear factor kappaB legend (RANKL) in the regulation of bone in humans remain unclear. We examined the sex-specific associations of serum OPG, RANKL, and their ratio with bone mineral density (BMD) in older adults. DESIGN:Participants were 681 community-dwelling adults, ages 45-90 years, who had serum OPG and RANKL measured and bone density scans in 1988-1991, with follow-up scans 5 and/or 10 years later. METHODS: Analyses were sex-specific; women using and not using estrogen were evaluated separately. Cross-sectional analyses used multivariable regression models; longitudinal analyses used repeated measures mixed effects models. RESULTS: In cross-sectional analyses, age- and weight-adjusted serum OPG levels were significantly positively associated with BMD at the lumbar spine in men, and at the femoral neck, total hip, and lumbar spine in women using estrogen, but not in non-users of estrogen. RANKL concentrations were significantly and inversely associated with BMD in men only, and at the total hip. Neither OPG nor RANKL was significantly associated with bone loss. Results for the RANKL/OPG ratio were the same as those for RANKL alone. CONCLUSIONS: These results suggest a modulatory effect of both endogenous and exogenous sex hormones on the biologic interaction of OPG, RANKL, and bone.
Authors: S Khosla; H M Arrighi; L J Melton; E J Atkinson; W M O'Fallon; C Dunstan; B L Riggs Journal: Osteoporos Int Date: 2002-05 Impact factor: 4.507
Authors: Tim Cundy; Madhuri Hegde; Dorit Naot; Belinda Chong; Alan King; Robyn Wallace; John Mulley; Donald R Love; Joerg Seidel; Matthew Fawkner; Tatjana Banovic; Karen E Callon; Andrew B Grey; Ian R Reid; Catherine A Middleton-Hardie; Jillian Cornish Journal: Hum Mol Genet Date: 2002-09-01 Impact factor: 6.150
Authors: P Rozas Moreno; R Reyes García; A García-Martín; M Varsavsky; J A García-Salcedo; M Muñoz-Torres Journal: J Endocrinol Invest Date: 2012-02-28 Impact factor: 4.256
Authors: Amber S Kujath; Lauretta Quinn; Mary E Elliott; Krista A Varady; Tamara J LeCaire; C Sue Carter; Kirstie K Danielson Journal: Diabetes Metab Res Rev Date: 2014-09-03 Impact factor: 4.876
Authors: Jonathan A Mitchell; Alessandra Chesi; Okan Elci; Shana E McCormack; Sani M Roy; Heidi J Kalkwarf; Joan M Lappe; Vicente Gilsanz; Sharon E Oberfield; John A Shepherd; Andrea Kelly; Struan Fa Grant; Babette S Zemel Journal: J Bone Miner Res Date: 2015-12-14 Impact factor: 6.741
Authors: M Kyla Shea; Gerard E Dallal; Bess Dawson-Hughes; José M Ordovas; Christopher J O'Donnell; Caren M Gundberg; James W Peterson; Sarah L Booth Journal: Am J Clin Nutr Date: 2008-08 Impact factor: 7.045
Authors: V Breuil; M Ticchioni; J Testa; C H Roux; P Ferrari; J P Breittmayer; C Albert-Sabonnadière; J Durant; F De Perreti; A Bernard; L Euller-Ziegler; G F Carle Journal: Osteoporos Int Date: 2009-10-30 Impact factor: 4.507